Gland Pharma Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Gland Pharma Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
GLAND

Click to see a quick summary and important updates about this stock!Dismiss

Gland Pharma Ltd.

BSE: 543245, NSE: GLAND

  • Market Capitalisation info

    ₹39,517 Cr


  • 12 Month Earnings info

    ₹1,090 Cr

  • Price to Earnings info

    36.25

₹2,396.75

As on 18-Aug-2022 13:14 IST

up-down-arrow26.701.13%

  • Prev Close info

    2,370.05

  • Day's Openinfo

    2,370.00

  • Today's Highinfo

    2,425.00

  • Today's Lowinfo

    2,355.00

  • Today's Volumeinfo

    1,22,284

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Gland Pharma
-37.98 -2.82 -22.80 -41.73 -- -- --
S&P BSE Healthcare
-11.55 2.60 2.34 -11.61 22.94 12.01 12.19
S&P BSE Mid Cap
1.09 10.45 11.20 9.46 23.22 10.64 15.15
As on 18-Aug-2022
2021
Gland Pharma
63.08
S&P BSE Mid Cap
39.18
S&P BSE Healthcare
20.87

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis

        No Review & Analysis are available.

        Other Details

        Incorporated

        1978

        Chairman

        Yiu Kwan Stanley Lau

        Managing Director

        Srinivas Sadu

        Headquarters

        Hyderabad, Telangana
        Edit edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          ₹39,516.60 Cr

        • Revenue (TTM) info

          ₹4,103.71 Cr

        • Earnings (TTM) info

          ₹1,090.18 Cr

        • Cash info

          ₹3,248.32 Cr

        • Total Debt info

          ₹3.93 Cr

        • Promoters' ownership info

          57.87%

        • Liquidity info

          High

        • 52 Week range info

          ₹2,180.00 - 4,179.65

        • Face value info

          ₹1.00

        • Shares outstanding info

          16,46,55,923

        • 10 Years Aggregate:

          CFO: ₹3,617.37 Cr

          EBITDA: ₹7,047.19 Cr

          Net Profit: ₹5,073.08 Cr

        About The Company

        • Business

          Manufacture of allopathic pharmaceutical preparations

        • Incorporated

          1978

        • Chairman

          Yiu Kwan Stanley Lau

        • Managing Director

          Srinivas Sadu

        • Listing info

          BSE: 543245, NSE: GLAND

        • Country

          India

        • Headquarters info

          Hyderabad, Telangana

        • Website info

          www.glandpharma.com